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Introduction. EVAR has the potential to improve outcome after ruptured abdominal aortic aneurysm (AAA). Published
series have been based upon selected populations.
Methods. An interim analysis of a single centre prospective randomised controlled trial comparing endovascular aneu-
rysm repair (EVAR) with open aneurysm repair (OAR) in patients with ruptured AAA was performed. Patients who
had a ruptured AAA and who were considered fit for open repair were randomised to EVAR or OAR after consent had
been obtained. Those in the EVAR group had pre-operative spiral computed tomographic angiography (CTA). The primary
endpoint was operative (30-day) mortality and secondary endpoints were moderate or severe operative complications, hos-
pital stay and time between diagnosis and operation. A power study calculation required 100 patients to be recruited.
Results. Between September 2002 and December 2004, 103 patients were admitted with suspected ruptured AAA. Only
32 patients were recruited to the study. Of these, four patients died before receiving surgical treatment. On an intention to
treat basis the 30-day mortality rate was 53% in the EVAR group and 53% in the OAR group. Moderate or severe oper-
ative complications occurred in 77% in the EVAR group and in 80% in the OAR group. Median total hospital stay in the
EVAR group was 10 days (inter-quartile range 6e28) and 12 days (4e52) in the OAR group. Median time between
diagnosis and operation was 75 minutes (64e126) in the EVAR group and 100 minutes (48e138) in the OAR group.
Conclusions. Despite the relative high operative mortality in the EVAR group, these preliminary results show that it is
possible to recruit patients to a randomised trial of OAR and EVAR in patients with ruptured AAA. CT scanning does not
delay treatment.
Keywords: Abdominal aortic aneurysm; Ruptured aneurysm; Randomised controlled trial; EVAR; Open aneurysm repair.Introduction
Endovascular aneurysm repair (EVAR) has become
an accepted and widely performed technique for the
management of elective abdominal aortic aneurysm
(AAA). Recent multicentre randomised controlled
trials have confirmed that it can be performed with re-
duced peri-operative morbidity and mortality com-
pared with open repair.1,2 Patients, who are critically
ill with ruptured AAA, could be the most likely to
benefit from a less invasive procedure. However,
over a decade since it was first described, EVAR of
ruptured AAA has not been widely adopted.3
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EVAR of ruptured AAA they also identified issues
surrounding the new technique notably aneurysm
morphology, logistics and stent-graft requirements.4,5
Recent publications suggest these problems may
have been surmounted. Refinements of the technique
have shown EVAR can be performed with lower peri-
operative morbidity and mortality than may have
been expected with open repair.6,7 The results of these
studies may have been biased by patient selection.
Currently, there is no level one evidence to support
the widespread adoption of EVAR in an unselected
population of patients who present with ruptured
AAA.8
In order to test the hypothesis that EVAR can re-
duce the peri-operative mortality of ruptured AAA,
a single centre prospective randomised controlled
trial comparing EVAR with open repair of ruptured
AAA was performed.rved.
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This was a single centre randomised controlled trial
performed on an intention-to-treat basis. The study
received local ethics committee approval. In addition,
the problems of informed consent were discussed at
length by an independent ethics of clinical practice fo-
rum consisting of members of the Judiciary, religious
representatives, members of the public, family practi-
tioners and senior hospital doctors who were not vas-
cular surgeons. Recruitment began in September 2002.
Results presented include all patients recruited be-
tween 1st September 2002 and 31st December 2004.
Power calculations were based on the mortality
rate for open aneurysm repair in our unit which
was 50 percent. Interpolation of a pilot study in
emergency EVAR in our unit suggested an expected
outcome of 25% mortality rate for EVAR. It was
thought that some 10% of patients randomized to
EVAR might not be suitable and would require open
repair. Of those, 5% could die. It was calculated that
100 patients had to be recruited to have a 90% power
to show a statistically significant (5% chance of error)
reduction in mortality rate to 25%.
Trial entry criteria were kept as broad as possible
in order to encourage recruitment and reduce bias
(Table 1). All patients admitted to the University
Hospital, Nottingham with clinically suspected or
radiologically confirmed rupture of an infra-renal
abdominal aortic aneurysm that, in the opinion of the
duty consultant vascular surgeon, would normally
be treated with open repair were eligible.
Recruitment
There were several logistical and ethical hurdles that
had to be addressed before recruitment could proceed.
As the level of endovascular experience varied be-
tween the five surgeons on the unit, the first require-
ment was that the surgeon and team available had
Table 1. Patient exclusion criteria
Exclusion criteria
No endovascular team available
Full selection of emergency stent-grafts not available
Age< 50 years
Inability to give verbal or written consent
Unconscious patient
Allergy to radiological contrast, stainless steel or polyester
Severe co morbidity that would preclude intensive care treatment
following open repair
Previous endovascular AAA repair
Women of child bearing potential not taking contraception
Pregnant and lactating womensufficient expertise to offer EVAR, if not conventional
OAR was offered.
Ethical issues also had a direct bearing on the
recruitment, which occurred as follows: Since ran-
domisation could result in open repair, only patients
considered suitable for open repair of their ruptured
aneurysm were randomised. In addition, because of
potential concern that very unstable patients might
be disadvantaged by the delay incurred during CT
scanning, the surgeon could at their discretion not
randomise patients and take them directly to the oper-
ating theatre for OAR.
Before a patient could be recruited, sufficient mem-
bers of the EVAR team had to be present. The essential
components of the team were a consultant vascular
surgeon trained in EVAR and a radiographer familiar
with the mobile image intensifier. Desirable, but not
essential members of the team were a vascular radiol-
ogist and a junior surgeon to act as assistant.
According to the rules set by the ethics of clinical
practice committee, verbal or written consent was
taken after the clinical diagnosis of ruptured AAA
had been made.9 Patients were read a standard infor-
mation card by the attending vascular surgeon and
the consent process was witnessed by an unrelated
healthcare professional. Randomisation was then per-
formed from sealed opaque envelopes kept in the
Accident and Emergency Department.
Any patients in whom there was diagnostic uncer-
tainty had a CT scan. In these cases, entry to the study
and randomisation took place at the time of CT diag-
nosis. The surgeons were blinded to the dimensions of
the patient’s aorta until randomisation had taken
place. This was to avoid bias if the CT subsequently
showed an aneurysm that was not suitable for
EVAR, when the surgeons might not have offered trial
entry.
Patients randomised to open repair were trans-
ferred directly to the operating theatre according
to local practice. Those randomised to EVAR were
transferred for aortic measurement using computer-
ised tomography (CT) scanning prior to transfer to
the operating theatre (Fig. 1). Those who had a diag-
nostic CT were transferred to the operating theatre.
Aneurysm morphology was assessed using spiral
CTA on a spiral unit following the standard local pro-
tocol. Scans were performed from upper L1 to the
symphysis pubis to ensure coverage of the aneurysm
from the visceral aorta to the external iliac arteries,
with 5 mm collimation, 3 mm index, 1.5:1 pitch,
with exposure factors of 120 kVp and 225 mA. Con-
trast was injected with a pump injection of 50 ml
Omnipaque 300 with a typical delay of 20 seconds,
at a rate of 3 ml per second. No medication was givenEur J Vasc Endovasc Surg Vol 32, November 2006
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repair
Intravenous access, give oxygen, cautious intravenous fluid administration 
Informed consent to enter the trial 
Randomisation by opening of sequentially numbered opaque envelope
Open Repair Endovascular Repair 
Contact anaesthetist 
and theatre staff 
Contact radiographer, radiologist, 
anaesthetist and theatre staff 
Transfer immediately 
to theatre Transfer to CT scanner 
Obtain CT measurements 
(see morphological contraindications for EVAR)
Standard anaesthesia 
for open repair 
↓↓ ↓
Unsuitable for EVAR Suitable for EVAR 
Transfer immediately to
theatre
 
Transfer immediately to
theatre
 
Standard anaesthesia for 
open repair 
Local anaesthesia to groins. 
When device ready for 
deployment, give general 
anaesthesia. 
Fig. 1. Flow diagram of patients entered in to the trial.to reduce contrast-induced nephropathy. The contrast
load was less than the standard volume for elective
scans as only 3 measurements were required for graft
planning: diameter of aortic neck, length of aortic
neck and iliac artery diameters. Patients were deemed
suitable for EVAR if, in the opinion of the operating
surgeon, they could perform the repair (Table 2).
The department had experience of some 350 elective
and 35 emergency EVARs at the start of the study.
Neck diameters of 32 mm or less and neck lengths
of 5 mm or more were deemed suitable as the pa-
tients were in a different situation to those whoEur J Vasc Endovasc Surg Vol 32, November 2006required elective repair. It was accepted that some pa-
tients might need secondary interventions at a later
date but the role of the procedure was to arrest hae-
morrhage and allow resuscitation to a near normal
physiological state.
The endovascular procedure was performed in
a dedicated vascular operating theatre using a Siremo-
bil 2000 image intensifier (Siemens, Erlangen,
Germany) with digital subtraction angiography facili-
ties. Local anaesthetic was infiltrated in both groins
(1% lidocaine). Oblique or vertical groin incisions
were used and the stent-graft inserted via theTable 2. Morphological exclusion criteria
Absolute contra-indications Relative contraindications
No evidence of aneurysm rupture Proximal neck length <10 mm
Juxta-renal aneurysm Excessive thrombus in the proximal neck
Neck diameter >32 mm Common iliac artery length <25 mm
External iliac artery diameter <6 mm Heavily calcified iliac arteries
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commenced prior to deployment of the stent-graft as
the pain from temporary limb ischaemia had been
found to make patients restless and unco-operative.
Most patients were systemically heparinised. All pa-
tients received a two-piece aortouniiliac stent-graft
made with Gianturco stents with an uncovered supra-
renal component. At each procedure, the surgeon had
a choice of proximal stent diameters of 34 mm,
30 mm, 26 mm and 22 mm. The distal (iliac) limbs
available were 24 mm, 20 mm, 16 mm and 12 mm.
An occluding device was used in the contralateral
common iliac artery (Zip plug - Cook Europe, Copen-
hagen, Denmark or Endomed, Arizona, USA).5 After
deployment of the stent-graft and exclusion of the
aneurysm, a femoro-femoral cross-over graft was
performed (Gelsoft, Vascutek, Renfrewshire, UK). A
consultant vascular surgeon did all procedures. A
consultant radiologist was sometimes involved in as-
sessing the CTs.
A policy of permissive hypotension was started on
admission in all cases until the surgeon informed the
anaesthetic team that the aneurysm had been
excluded from the circulation. Fluid resuscitation
was then instituted. Intra-aortic balloon insertion
was not used. Patients were transferred to the vascu-
lar ward, high dependency unit or intensive care unit,
depending on their status at the end of the procedure.
Follow up of survivors of EVAR involved a post-
operativeduplexultrasound to exclude a large endoleak
followed by A CTscan prior to discharge from hospital.
Open repair was performed transperitoneally ei-
ther by midline or transverse incisions according to
the operating surgeon’s preferred method. All cases
were under general anaesthesia. The aorta was
clamped below the renal arteries. Patients were not
heparinised. An inlay technique was used in all
patients and grafts were gelatin-coated polyester
(Gelseal or Gelsoft, Vascutek, Renfrewshire, UK). A
consultant vascular surgeon performed all operations.
Patients were transferred to the intensive care unit for
standard postoperative care.
The results of a planned interim analysis are shown
below:
All results are expressed as medians with inter-
quartile ranges in parenthesis. Peri-operative mortal-
ity was defined as 30-day or in-hospital mortality.
Mortality was assessed both on an intention to treat
basis and on peri-operative mortality of each proce-
dure in isolation.
Outcomes were classified according to the Ad Hoc
Committee on Reporting Standards, Society for Vas-
cular Surgery and North American Chapter, Interna-
tional Society for Cardiovascular Surgery.10Patients
Between 1st September 2002 and 31st December 2004,
some 103 patients were diagnosedwith a ruptured aor-
tic aneurysm (Fig. 2). Seventy-one patients admitted
with a diagnosis of ruptured AAAwere not recruited.
Of these, 55 were either moribund or refused surgical
intervention. The essential components of the team
were not available for eight patients and they went
on to have open repair. Some six patients were thought
to be ‘too haemodynamically unstable’ for CT scan.
They were taken to theatre for open repair and all
died within 30 days. Two patients were not thought
suitable for open repair and were not recruited. They
had EVAR done on compassionate grounds. One
died from respiratory failure following an anaesthetic
complication. The other was discharged home.
Some 32 patients were recruited to the study, 17
were randomized to open repair (Fig. 2). All patients
randomized in the trial were subsequently discovered
to have ruptured AAA at CT or laparotomy.
Patient characteristics in the two treatment arms
were similar (Table 3.) A total of five patients under-
going EVAR and six undergoing open repair were
admitted with a systolic blood pressure less than
100 mmHg (unstable patients).
The median time between clinical diagnosis and op-
eration was 75 minutes (inter-quartile range 64e126)
in the EVAR group and 100 minutes (46e138) in the
OAR group (Table 4). The operative times and fluid re-
placements are given in Table 5.
Outcome of Patients Randomized to Open Repair
Of the 17 patients randomized to OAR three died
before they could reach theatre. Of the 14 in whom
the operation was commenced, two died on table
and 12 survived the operation. A further four died
in the peri-operative period. This gives a mortality
of 9/17 (53%) on an intention-to-treat by conventional
open aneurysm repair. The peri-operative mortality of
those surviving to reach theatre to undergo open
repair was 6/14 (43%).
In the OAR group, one patient was converted to an
axillo-bifemoral graft due to the presence of an un-
suitable proximal aortic neck. He survived the opera-
tion but developed respiratory failure from which he
recovered. He was discharged home with a low-grade
graft infection treated with antibiotics.
In the OAR group, there were three inadvertent in-
juries intra-operatively including damage to the renal
and gonadal veins and renal artery occlusion. Three
patients required femoral embolectomy, for distal
510 R. J. Hinchliffe et al.103 suspected ruptured AAAs 
71 non- randomised patients 
 32 randomised patients
15 randomised to EVAR
 
1 patient died 
prior to CT
14 underwent spiral CTA 
1 converted to OAR 1 converted to axillo-
bifemoral graft 
1 converted to axillo-
bifemoral graft 2 procedures abandoned
13 underwent EVAR
1 morphologically unsuitable
for EVAR
 
3 patients died
prior to theatre
14 underwent attempted OAR
17 randomised to OAR 
11 EVAR completed 12 primary OAR completed 
• Reasons not to randomise:
 Not fit for open repair, died in A&E before randomization, unable to give informed consent (unconscious),
 age, refusal of operation, no team available, surgeon thought open repair more appropriate
• EVAR group:
  -        1 converted to open due to intra-operative technical error (graft was pulled down)
  -        1 patient needed conversion to axillo-bifemoral bypass because the graft clotted
• OAR group:
  -      1 patient needed conversion to axillo-bifemoral bypass because of an unusable neck.
  -      2 procedures were abandoned due to exsanguination
15 underwent OAR
Fig. 2. CONSORT diagram of outcome of patients admitted with a suspected diagnosis of ruptured AAA during the trial
period.embolisation. One patient required laparostomy- he
had presented with a two week history of abdominal
pain and had such a large haematoma that the operat-
ing surgeon felt primary closure would have resulted
in abdominal compartment syndrome. There were
also three re-operations within the first twenty-four
hours for bleeding related to the aneurysm repair.Eur J Vasc Endovasc Surg Vol 32, November 2006Outcome of Patients Randomized to EVAR
Fifteen patients were randomized to EVAR. One died
during transfer to CT and one underwent open repair
because of unsuitable morphology detected in CT e
the aneurysm neck was too wide for the available de-
vices. He underwent open repair from which he made
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only complication being urinary retention.
Thirteen patients had attempted EVAR. Two re-
quired conversion to an open procedure. One patient
was converted to open repair because of a technical
error (the top stent was caught in the delivery system
by the operating surgeon). This patient died 10 days
Table 3. Baseline patient characteristics
Patient demographics EVAR OAR
Median (inter-quartile range),
(number)
Age 74 (68.8e79.5) 80 (73.8e83.8)
Male 11 13
Ischaemic heart disease 3 5
Chronic obstructive
airways disease
0 3
Peripheral vascular
disease
1 2
Renal disease 1 2
Hypertension 5 8
Active smoker 4 6
Ex-smoker 8 3
Known AAA 3 7
Abdominal/back pain 6 9
Collapse 7 6
Loss of consciousness 2 2
Symptom
duration (minutes)
210 (110e1440) 590 (83e2520)
Systolic blood pressure
on arrival Aþ E (mmHg)
119 (93e155) 120 (85e138)
Systolic blood pressure
on arrival theatre (mmHg)
110 (96e140) 120 (100e134)
Crystalloid given
in Aþ E (ml)
625 (0e1500) 750 (0e1000)
Colloid solution given
in Aþ E (ml)
100 (0e1000) 250 (0e1000)
Haemoglobin on arrival
in Aþ E (g/dl)
10.9 (8.2e13.2) 11.3 (10.3e13.1)
Haematocrit 0.33 (0.25e0.4) 0.35 (0.32e0.39)
White cell count (109/l) 13.0 (10.7e16.1) 11.5 (8.6e15.1)
Platelets (109/l) 182 (144e285) 203 (153e277)
Urea (mmol/l) 7.1 (5.8e9.2) 7.6 (7.1e10.7)
Creatinine (umol/l) 110 (96e175) 133 (116e152)
Table 4. Pre-operative CT derived aneurysm measurements in
patients who had EVAR
Morphological variable Measurement (mm)
Median (inter-quartile range)
Maximum AAA diameter 85 (80e100)
Supra-renal diameter 28 (25e31)
Neck lengtha 15 (9e22)
Neck diameter 26 (23e29)
Renal artery e aortic bifurcation 131 (126e147)
Right common iliac artery length 48 (38e55)
Left common iliac artery length 50 (38e53)
Right common iliac artery diameter 16 (13e20)
Left common iliac artery diameter 16 (14e21)
Right external iliac artery diameter 10 (8e11)
Left external iliac artery diameter 10 (8e11)
*Three patients had free intra-peritoneal rupture on CT.
a One patient with short neck deemed unsuitable for EVAR and
underwent OAR.post-operatively from a combination of respiratory
failure, stroke and myocardial infarction. Another
patient was converted to an axillo-bifemoral graft
because of a stent-graft thrombosis. The thrombosis
occurred because of a combination of a stenosis in
the common iliac artery and a surgical error in not
withdrawing the delivery system into the external
iliac artery to allow flow in to the internal iliac artery.
This patient survived. All subsequent patients who
had EVAR were given systemic heparin (3000 to
5000 units) before graft insertion as is the standard
practice with elective repair.
A total of 11 EVARs were successfully completed.
A further six patients died peri-operatively. No pa-
tients were diagnosed with intra-abdominal compart-
ment syndrome. On an intention to treat basis, 8/15
(53%) of patients randomized to EVAR died. The
operative mortality in those who had a completed
EVAR procedure was 6/13 (46%).
In the EVAR group, 77% of patients had moderate
or severe complications compared with 80% in the
OAR group (Table 6). The median total hospital stay
in the EVAR group was 10 days (6e28) compared
with 12 in OAR (4e52).
More patients in the EVAR group suffered severe
renal complications (6 (55%) versus 1 (8%) in OAR,
p¼ 0.02).
In the patients undergoing EVAR, there were two
additional endovascular interventions and two open.
A Palmaz stent (Johnson and Johnson) was deployed
intra-operatively for type 1 endoleak and in another
patient a Palmaz stent was used to seal a proximal
(type 1) endoleak detected by postoperative investiga-
tions. The two conversions to open repair are noted
above.
Discussion
This is the first study to report a randomized trial be-
tween EVAR and OAR in patients who present with
a ruptured AAA.
The study shows that it is possible to perform an
ethical randomized study of EVAR compared with
open repair for ruptured AAA.
Concerns that CT scanning prior to surgery causes
detriment to the patient appear to be misplaced. Pa-
tients who were so unstable that the surgeon deemed
CT scanning unethical did badly with open repair.
These patients may even be those who have most to
gain from endovascular repair. The time interval be-
tween arrival and operation was similar in the two
groups with the open repair having a slightly longer
delay. This may be a chance event or reflect that the
open repair group had a higher proportion of patients
512 R. J. Hinchliffe et al.in whom there was diagnostic delay. Provided CT
scan can be performed promptly it need not cause
unnecessary delay or detriment.
The finding that mortality rates were comparable in
open and endovascular groups was disappointing
and at variance with our own previous experience
of endovascular repair in selected rupture cases and
those in the literature. This may reflect that selected
case series invariably produce better results than
randomised controlled studies and provide support
for a further multicentre study with larger numbers
of patients. Certainly given that there was not a clear
superiority of one technique over the other it con-
tinues to be ethical to randomize patients between
the two techniques. There may be other contributory
factors including patient selection and the experience
of the team available.
The most commonly used proximal graft size was
34 mm in diameter. This confirms previous studies that
ruptured aneurysms are often associated with large
diameter necks.11 It was possible to successfully
exclude aneurysms with angulated and short necks.
In an elective situation, this would not have been
attempted. When faced with a patient about to die,
the study protocol allowed the vascular surgeon to
use EVAR if they felt there was a reasonable chance
of successful exclusion of the aneurysm. As was noted
in one patient, pushing the anatomical limits of EVAR
for rupture resulted in two proximal endoleaks. Both
of these were treated by endovascular means. This
analysis has shown that the measurement guidelines
for elective EVAR can be ignored in patients with
ruptures. If there are problems with the device then
a secondary intervention can be done when the
patient is physiologically better than at the time of
presentation.
One of the disadvantages of the aortouniiliac sys-
tem is that all patients needed general anaesthesia.
Although guide-wire placement and graft delivery
could be done under local anaesthesia in the groin,
the ischaemic pain during the femoro-femoral cross-
over was too painful for most patients. In the study
almost two-thirds of EVAR patients consequently suf-
fered a severe respiratory complication. Some centres
have used bifurcated stent-grafts under local anaes-
thesia with encouraging results.7 The disadvantage
of that system is the need for a potentially difficult
catheterisation in a patient who continues to bleed
through the contralateral stump. Some refinement
of technique may be helpful in these situations.
The use of an occluding balloon for bifurcated
grafts may also be an important adjunct.12 Another
disadvantage in using a bifurcated system may be
the need to have a large stock of main body systems.Eur J Vasc Endovasc Surg Vol 32, November 2006The only significant finding was EVAR resulted in
less blood loss and a statistically significant reduction
in blood product usage (Table 5). This is unlikely to be
sufficient evidence to recommend that EVAR is better
than OAR when mortality remains similar.
Units, which decide to adopt EVAR for ruptured
AAA, must be aware of the need for renal support
post-operatively. A large proportion of patients devel-
oped renal failure in the endovascular arm of the trial.
Potential causes may be atherosclerotic embolisation
or contrast nephropathy. The volume of contrast given
Table 5. Fluid replacement and operative times
Procedural
characteristics
EVAR (N¼ 13) OAR (N¼ 15) P value
Duration in
theatre (mins)a
160 (150e234) 150 (141e204) 0.34
Estimated blood
loss (ml)
200 (163e450) 2100 (1150e3985) 0.004
Blood products transfused
Autologous
blood (ml)
0 222 (0e500) 0.004
Homologous
blood (units)
3.0 (0e5) 6.0 (4e9) 0.02
Fresh Frozen
Plasma (units)
0 (0e0.5) 0 (0e2) 0.12
Platelets (units) 0 0 e
Intravenous fluid administration
Crystalloids (ml) 2000 (1375e3125) 2000 (1000e3000) 0.39
Colloids (ml) 1000 (500e1500 1750 (1000e2600) 0.01
a Duration in theatre was taken from the start of the anaesthetic to
the patient exiting the operating theatre.
Table 6. Post-operative complications
Systemic
complications
EVAR (N¼ 11) OAR (N¼ 12)
Number
Renal
Moderate 1 4
Severe 6 1
Pulmonary
Moderate 4 1
Severe 7 6
Cardiac
Moderate 5 6
Severe 0 1
Cerebrovascular
Moderate 0 0
Severe 1 0
Coagulopathy
Moderate 1 1
Severe 1 1
Other
Moderate 2 4
Severe 1 2
Complications classified according to the reporting standards of the
Ad Hoc Committee for Standardized Reporting Practices in Vascu-
lar Surgery of the Society for Vascular Surgery/International Society
for Cardiovascular Surgery.10
Patients who died intra-operatively are excluded from analysis.
513A Randomised Trial of Endovascular and Open Surgery for Ruptured AAAto these patients was considerably greater than in an
elective situation. In addition to the contrast given at
CT (50 ml) they also had a median of 150 ml intra-
operatively. Large contrast volumes and intravascular
depletion are recognised risk factors for the develop-
ment of contrast-induced nephropathy.13 Difficult
aneurysm morphology, requiring very precise deploy-
ment of the stent-graft was a contributory factor to the
large volumes of contrast used. This was compounded
by the presence of retroperitoneal haematoma and
a low cardiac output, both of which deteriorate angio-
graphic images. In an attempt to reduce renal injury,
the CT protocol had been changed to a reduced volume
and diluted contrast is given in theatre. Another solu-
tion to renal complications may be to provide haemo-
filtration for all patients following EVAR.14 The use
of N-acetyl cysteine as a free radical scavenger relies
upon pre-contrast administration and is therefore
unlikely to be beneficial. There is some evidence that
NaHCO3 infusions reduce renal problems- it may be
worth using these infusions in the future.
The study shows that nearly 47% of patients admit-
ted with a ruptured AAA are not deemed suitable for
open aneurysm repair. It also shows that in an unse-
lected population, a trial with 100 patients is unlikely
to be sufficiently powerful to show a difference in the
2 techniques. Much larger studies will be required to
obtain level one evidence. This study has been sus-
pended but we believe provides useful information
for those considering similar studies in future.
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